The Centers for Medicare & Medicaid Services today issued guidance on designing state approaches to covering treatment services for Medicaid-eligible infants with neonatal abstinence syndrome. “Through discussions with states, we have recognized their growing challenge in providing treatment services to the expanding number of infants with NAS,” said Tim Hill, acting director of the Center for Medicaid and CHIP Services. “We have also recognized that states may not be fully aware of available options under Medicaid that can play a critical role in the care of these infants, as well as the limitations on Medicaid coverage.” In addition, CMS issued a letter to state Medicaid directors on funding authorities that may support health information technology efforts to address the opioid crisis.

Related News Articles

Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and…
Headline
The White House July 23 released an action plan with a series of more than 90 policy recommendations to expand the use of artificial intelligence. The plan…
Headline
The Congressional Budget Office today released its estimate of the budgetary effects of the One Big Beautiful Bill Act, as enacted. CBO projects the law will…
Headline
The Centers for Medicare & Medicaid Services July 17 issued two letters to states regarding policies on continuous eligibility and workforce initiatives.…